First Horizon Advisors, Inc. Dyne Therapeutics, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.53 Billion
- Q1 2025
A detailed history of First Horizon Advisors, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 134 shares of DYN stock, worth $1,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134
Previous 156
14.1%
Holding current value
$1,579
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DYN
# of Institutions
208Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$94.5 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$87.1 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$87 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$79 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$75.2 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $610M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...